Stepwise Optimization and Transcription Factor Engineering for Efficient Ectoine Production in Escherichia coli
ACS Synthetic Biology · 09.11.2026
DOI: 10.1021/acssynbio.6c00727 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 09.11.2026. Verfasst von Yujia Zheng und 7 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ectoine, a high-value compatible solute, is widely used in cosmetics, biopharmaceuticals, and the pharmaceutical industry. Although non-halophilic chassis such as Escherichia coli are preferred for industrial ectoine production, unclear metabolic distributions and physiological constraints have limited titers and productivity. Here, we report a systematic metabolic engineering strategy for high-performance ectoine biosynthesis in E. coli. Introduction of the ectoine gene cluster from Halomonas elongata, coupled with enhanced flux from phosphoenolpyruvate to l-aspartate-β-semialdehyde, established de novo ectoine production. Combinatorial optimization for promoters and expression of an EctBE407D variant collectively increased the ectoine titer by 353% in strain ECT08. Furthermore, the supply of synthetic precursors l-glutamate and oxaloacetic acid was enhanced, elevating the bioproduct to 9.09 g/L in strain ECT18, coupled with a deliberate downregulation of the TCA cycle flux. Transcriptional regulator screening further identified Lrp as a growth-coupled engineering target, whose manipulation enhanced both titer and biomass by 19.83% and 28.62%, respectively. Importantly, metabolic profiles indicated that the Lrp supervised a multi-node regulatory program that alleviated carbon supply, precursor conversion, nitrogen donor availability, and energy efficiency. In fed-batch fermentation, the final strain ECT31 was cultivated in a 7 L bioreactor and induced at 10 h, producing 81.39 g/L ectoine with a yield of 0.31 g/g and a productivity of 0.75 g/L/h. These systematic strategies establish a robust paradigm for the efficient microbial production of aspartate-derived compounds.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zheng, Y., Li, Y., He, Q., Liu, J., Bai, Z., Fu, H., Zhou, Y., & Wang, J. (2026). Stepwise Optimization and Transcription Factor Engineering for Efficient Ectoine Production in Escherichia coli. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00727
Vancouver
Zheng Y, Li Y, He Q, Liu J, Bai Z, Fu H, et al. Stepwise Optimization and Transcription Factor Engineering for Efficient Ectoine Production in Escherichia coli. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00727
BibTeX
@article{Zheng2026,
author = {Zheng, Yujia and Li, Yang and He, Qian and Liu, Jiaxin and Bai, Zhijia and Fu, Hongxin and Zhou, Yang and Wang, Jufang},
title = {Stepwise Optimization and Transcription Factor Engineering for Efficient Ectoine Production in Escherichia coli},
journal = {ACS Synthetic Biology},
year = {2026},
doi = {10.1021/acssynbio.6c00727}
}
EUVIMED